-
Novo Nordisk A/S (NVO $50.95)
-
Vanguard FTSE Developed Markets ETF (VEA $58.61)
-
ASML Holding N.V. (ASML $755.21)
-
iShares MSCI Intl Quality Factor ETF (IQLT $42.98)
Q: I've owned IQLT for a few years now. I've noticed that the VEA top holdings are quite similar to IQLT, but at a significantly reduced MER. Is it really worth paying that much more to continue to hold IQLT? Maybe you have better insight on the differences between the two than I do (?)